je.st
news
Tag: sandoz
Shall Means Shall . . . Unless It Doesn't - Amgen Inc., et al. v. Sandoz, Inc.
2015-09-03 03:46:17| Biotech - Topix.net
Addressing issues of first impression related to the Biologics Price Competition and Innovation Act of 2009 , which the U.S. Court of Appeals for the Federal Circuit labeled "a riddle wrapped in a mystery inside an enigma," the Court affirmed dismissal of unfair competition and conversion claims under California law, but reversed the denial of a preliminary injunction. Amgen Inc., et al. v.
Federal Circuit Keeps Sandoz Biosimilar Off the Market for Now
2015-05-08 04:19:44| Biotech - Topix.net
The Federal Circuit is set to hear oral arguments in Amgen v. Sandoz on June 3, but in the meantime has granted Amgen's motion for a preliminary injunction to keep Sandoz' biosimilar version of Neupogen off the market until it renders its decision.
Tags: now
market
federal
circuit
Sandoz Inc. v. Amgen Inc.,
2015-02-16 16:58:53| Biotech - Topix.net
Case Name: Sandoz Inc. v. Amgen Inc., No. 2014-1693, 2014 U.S. App. LEXIS 22903 Drug Product and Patent -in-Suit: Enbrel ; U.S. Pats.
Sandoz loses bid to shield psoriasis drug
2014-12-06 15:03:21| Biotech - Topix.net
We use cookies to ensure that we give you the best experience on our website. By continuing to browse our site, you are giving your consent for us to set cookies.
Sites : [1]